Status:
COMPLETED
Profiling the Inflammatory Cascade of COVID-19
Lead Sponsor:
University of Edinburgh
Collaborating Sponsors:
NHS Lothian
Conditions:
COVID-19
Eligibility:
All Genders
16+ years
Brief Summary
COVID-19 is a new and poorly understood virus. It is imperative that the scientific community develops an understanding of the viral mechanisms and human immunological response in order to develop eff...
Detailed Description
The immuno-inflammatory cascade is essential to define in COVID-19 patients to develop an intervention strategy to abrogate respiratory failure. For this study, four groups of patients have been ident...
Eligibility Criteria
Inclusion
- All participants:
- Aged over 16 years
- Provision of consent (either from the patient or by a personal legal representative)
- COVID-19 Cohort only:
- Confirmed COVID-19 infection
- Control Cohort only:
- No clinical suspicion of COVID-19
Exclusion
- All participants:
- Deemed unsuitable for participation by attending clinician
Key Trial Info
Start Date :
May 12 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 10 2022
Estimated Enrollment :
41 Patients enrolled
Trial Details
Trial ID
NCT06511024
Start Date
May 12 2020
End Date
August 10 2022
Last Update
October 16 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Royal Infirmary of Edinburgh
Edinburgh, United Kingdom, EH16 4SA